(Part one of a four-part series)

In recent years, evidence supporting the use of psychedelics for the treatment of unmet mental health disorders such as PTSD, depression, addictions and anxiety has done nothing but grow.

Let’s dive into one of the substances emerging as potentially more therapeutic than traditional pharmaceutical solutions: psilocybin

The psychoactive component within “magic mushrooms” is currently approaching mainstream acceptance and being increasingly championed by veterans organizations, terminally-ill patients and U.S. officials

In addition to scientific publications, psilocybin has recently been featured in influential media outlets such as Bloomberg, The New York Times, Time Magazine and Vice

So far, results are showing that psilocybin is non-addictive and has a low risk of side effects. 

Yet dangers do exist, not only for those at risk of a severe psychiatric disorder but also for virtually anyone who would trip without a therapeutic framework. 

The goal is not to bring specific insights to …

Full story available on Benzinga.com